Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Clin Cancer Res. 2013 Mar 14;19(9):2473–2485. doi: 10.1158/1078-0432.CCR-12-3416

Table 2.

10-fold cross validation results for the full BM45 set and five subsets with 5, 10, 15, 20, and 25 top ranked attributes.

BM45 (88 end-points) Top 5 Top 10 Top 15 Top 20 Top 25
TP FP TP FP TP FP TP TP TP FP TP FP
S 31 14 31 14 33 12 33 33 35 10 36 9
L 35 10 32 13 40 5 40 40 40 5 39 6
Acc, % 73.3 70.0 78.9 81.1 83.3 83.3

S = short survivor class; L = long survivor class; Acc = accuracy; TP = true positive; FP = false positive.